Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis
2008

Curcumin Helps Fight Prostate Cancer

Sample size: 10 publication Evidence: high

Author Information

Author(s): Shankar Sharmila, Ganapathy Suthakar, Chen Qinghe, Srivastava Rakesh K

Primary Institution: University of Texas Health Science Center at Tyler

Hypothesis

Curcumin sensitizes TRAIL-resistant prostate cancer cells to apoptosis through various molecular mechanisms.

Conclusion

Curcumin can inhibit tumor growth, metastasis, and angiogenesis, and enhance the therapeutic potential of TRAIL for prostate cancer treatment.

Supporting Evidence

  • Curcumin inhibited the growth of LNCaP xenografts in nude mice.
  • Curcumin induced apoptosis and inhibited proliferation in tumor cells.
  • Curcumin upregulated death receptors and pro-apoptotic proteins.
  • Curcumin inhibited angiogenesis by reducing blood vessel formation.
  • Curcumin enhanced the effects of TRAIL on tumor cells.

Takeaway

Curcumin, a compound in turmeric, can help make prostate cancer cells more sensitive to treatment, which could help in fighting the disease.

Methodology

Prostate cancer cells were implanted in mice to study the effects of curcumin and TRAIL on tumor growth and related genes.

Participant Demographics

Balb c nude mice were used for the experiments.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-4598-7-16

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication